{"id":"W2797238574","doi":"10.1016/j.jaad.2018.04.013","title":"Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Etanercept; Psoriasis Area and Severity Index; Clinical endpoint; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Tumor necrosis factor alpha; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003948125,0.0003660841,0.002755917,0.0002050876,0.0001963481,0.000007005686,0.0005812909,0.0002177348,0.00002980455],"category_scores_gemma":[0.000214816,0.0001790219,0.0008554413,0.0002184924,0.002147592,0.0001032689,0.00006652047,0.0002490892,0.000006727478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008576604,"about_ca_system_score_gemma":0.0001912682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001725462,"about_ca_topic_score_gemma":0.00004146561,"domain_scores_codex":[0.9960226,0.001386087,0.001819925,0.0002555898,0.0001207795,0.0003949509],"domain_scores_gemma":[0.992339,0.002789152,0.004323199,0.000321782,0.0001848492,0.00004200601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9583101,0.003093268,0.0004511109,0.00003316847,0.009248665,0.00001213247,0.006286745,0.000007525674,0.01331239,0.00008757772,0.0008141838,0.008343183],"study_design_scores_gemma":[0.9082229,0.006050175,0.0002739366,0.00007176201,0.005580056,0.002129413,0.00290478,0.00007336857,0.07130894,0.00007936964,0.003146452,0.0001588606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981739,0.008567054,0.0001185478,0.005520285,0.0006167141,0.003218889,0.0001455694,0.000008145606,0.00006577068],"genre_scores_gemma":[0.9949126,0.004465026,0.0001509536,0.00005986658,0.0001473718,0.0001400608,0.000004493598,0.00002311351,0.0000965705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05799654,"threshold_uncertainty_score":0.7912892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03753779827924125,"score_gpt":0.345756602853417,"score_spread":0.3082188045741758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}